Caricamento...
酪氨酸激酶抑制剂联合化疗后行异基因造血干细胞移植治疗Ph(+)急性淋巴细胞白血病与异基因造血干细胞移植治疗Ph(−)急性淋巴细胞白血病的疗效比较
OBJECTIVE: To compare the efficacy of the Ph(+) acute lymphoblastic leukemia (ALL) patients treated with combination of tyrosine kinase inhibitors (TKI) and chemotherapy followed by allogeneic hematopoietic stem cell transplantation (allo-HSCT) and Ph(−)ALL patients with allo-HSCT. METHODS: A total...
Salvato in:
| Pubblicato in: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Editorial office of Chinese Journal of Hematology
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342638/ https://ncbi.nlm.nih.gov/pubmed/26304085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.07.014 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|